0.01Open0.01Pre Close0 Volume2 Open Interest22.50Strike Price0.00Turnover5355.42%IV25.97%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0153Delta0.0203Gamma1787.00Leverage Ratio-22.6535Theta0.0000Rho27.38Eff Leverage0.0000Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet